Promising clinical data surrounding Retatrutide , specifically the 120mg formulation branded as ZPHC, indicate a significant effect on physique reduction and related health factors. Scientists believe that this dual compound, affecting both GLP-1 and GIP receptors , has the potential to provide a substantial improvement in the management of overwe